Which ETFs hold GSK PLC (GSK)?
British drugmaker focused on vaccines and medicines for HIV, respiratory and cancer.
27 Australian ETFs hold GSK PLC, a Health Care company from United Kingdom. IXJ has the biggest weighting at 1.13%. Across these funds, Australian ETF investors own about $153m of GSK PLC.
The ETFs with the most GSK PLC
All 27 ETFs that hold GSK PLC, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell GSK PLC.
Common questions
Which ETF has the most GSK PLC?
IXJ (iShares Global Healthcare ETF) has the highest weighting, with 1.13% of the fund in GSK PLC.
What is the cheapest ETF that holds GSK PLC?
Of the ETFs where GSK PLC is at least 1% of the fund, IXJ has the lowest fee at 0.41% a year, with 1.13% in GSK PLC.
How much GSK PLC do I own with $10,000 in VGS?
About $11. VGS is the largest ETF that holds GSK PLC, and GSK PLC makes up 0.11% of it.
How many Australian ETFs hold GSK PLC?
27 ETFs listed on the ASX or TMX Australia hold GSK PLC, based on issuers' published holdings.